Genenta Science S.p.A. Statistics
Share Statistics
Genenta Science S.p.A. has 18.29M
shares outstanding. The number of shares has increased by 0.4%
in one year.
| Shares Outstanding | 18.29M |
| Shares Change (YoY) | 0.4% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 1.97% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 15 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 2.38K, so 0.01% of the outstanding
shares have been sold short.
| Short Interest | 2.38K |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.02% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | -5.42 |
| PS Ratio | 0 |
| Forward PS | 0.7 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Genenta Science S.p.A..
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.89,
with a Debt / Equity ratio of 0.
| Current Ratio | 6.89 |
| Quick Ratio | 6.89 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-895,804.23 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 15.8% in the
last 52 weeks. The beta is 0.65, so Genenta Science S.p.A.'s
price volatility has been higher than the market average.
| Beta | 0.65 |
| 52-Week Price Change | 15.8% |
| 50-Day Moving Average | 3.89 |
| 200-Day Moving Average | 4.38 |
| Relative Strength Index (RSI) | 62.99 |
| Average Volume (20 Days) | 20,458 |
Income Statement
| Revenue | n/a |
| Gross Profit | -41.58K |
| Operating Income | -11.73M |
| Net Income | -11.65M |
| EBITDA | -11.69M |
| EBIT | -11.73M |
| Earnings Per Share (EPS) | -0.64 |
Full Income StatementBalance Sheet
The company has 4.58M in cash and 0 in
debt, giving a net cash position of 4.58M.
| Cash & Cash Equivalents | 4.58M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -56.06M |
| Total Assets | 14.82M |
| Working Capital | 12.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -6.24M
and capital expenditures -4.47K, giving a free cash flow of -6.24M.
| Operating Cash Flow | -6.24M |
| Capital Expenditures | -4.47K |
| Free Cash Flow | -6.24M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
